Drugs / OXB-102
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03720418 | Oct 2018 → Apr 2022 | Parkinson disease | Sio Gene Therapies | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OXB-102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03720418 ↗ |
| Route | Other | “Neurosurgical delivery of OXB-102 (gene therapy) to the putamen” NCT03720418 ↗ |